Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China · Delayed Price · Currency is CNY 10.71
-0.05 (-0.46%)
Jun 18, 2026, 3:04 PM CST
SHE:002727 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, SHE:002727 stock has a consensus rating of "Buy" and an average price target of ¥14.86. The average 1-year stock price forecast is 38.75% higher than the current stock price, while the lowest is ¥13.50 (+26.05%) and the highest is ¥17.75 (+65.73%).
Price Target: ¥14.86 (+38.75%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:002727 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 0 | 2 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 3 | 5 |
Financial Forecast
Revenue This Year
18.05B
from 17.34B
Increased by 4.10%
Revenue Next Year
19.16B
from 18.05B
Increased by 6.16%
EPS This Year
1.05
from 0.42
Increased by 151.35%
EPS Next Year
1.31
from 1.05
Increased by 24.72%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.7B | ||
| Avg | 18.0B | ||
| Low | 17.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.1% | ||
| Avg | 4.1% | ||
| Low | 0.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.05 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 151.3% | ||
| Low | - |